Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised patients

HIGHLIGHTS

• who: Parisa Badiee from the From June , to June, immunocompromised patients with suspected probable/proven IA were admitted to Shiraz University Hospitals, southern Iran enrolled in this studyPatients with signs and symptoms of infection without a clear-cut diagnosis were excluded. The diagnosis of infection was established in high-risk patients (immunocompromised) with clinical signs and symptoms of IA, and lab examination tests according to the European Organization for Research and Treatment of Cancer and the Mycoses Study Group (EORTC/MSG) have published the research work: Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.